Fundraising Fox
Ambagon Therapeutics
Eindhoven, US · Founded 2020 · Delaware corporation · 15 employees on LinkedIn · 7 known investors
Find your way into Ambagon Therapeutics
Sign up to see every warm intro you have to Ambagon Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ambagon Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.
Founders & leadership
Ambagon Therapeutics was founded in 2020 by Christian Ottmann.
Board
Investors · 7
How we know: Droia Ventures's portfolio page · board seat on SEC Form D · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Inkef's portfolio page · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Mission Biocapital's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: MRL Ventures Fund's portfolio page · press coverage · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$55.4M disclosed across 3 rounds · 2021–2025
▶$5MraisedFeb 2025 · 4 investors · BiotechnologyRule 506(b)
- Melissa McCrackenDirector
- Josh SeidenfeldExecutive Officer
- Christian OttmannExecutive Officer
- Offering amount
- $12M
- Amount sold
- $5M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$45MraisedJun 2022 · 9 investors · BiotechnologyRule 506(b)
- Josh SeidenfeldExecutive Officer
- Michelle ArkinDirector
- Peter DudekDirector
- Roel BulthuisDirector
- Janwillem NaesensDirector
- Margarita ChavezDirector
- Nancy PryerExecutive Officer
- Christian OttmannExecutive Officer
- Adam RosenbergDirector
- Melissa McCrackenDirector
- Bryan MillerExecutive Officer
- Scott ClarkeExecutive Officer, Director
- Offering amount
- $85M
- Amount sold
- $45M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$5.4MraisedDec 2021 · 8 investors · BiotechnologyRule 506(b)
- Michelle ArkinDirector
- Nancy PryerExecutive Officer
- Christian OttmannExecutive Officer
- Margarita ChavezDirector
- Peter DudekDirector
- Janwillem NaesensDirector
- Bryan MillerExecutive Officer
- Roel BulthuisDirector
- Adam RosenbergDirector
- Josh SeidenfeldExecutive Officer
- Scott ClarkeExecutive Officer, Director
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ambagon Therapeutics do?
- Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.
- Who founded Ambagon Therapeutics?
- Ambagon Therapeutics was founded by Christian Ottmann in 2020.
- Who are Ambagon Therapeutics's investors?
- Ambagon Therapeutics's investors include Droia Ventures, Inkef, Mission Biocapital, MRL Ventures Fund, Nextech Invest, RA Capital, Syncona.
- How much funding has Ambagon Therapeutics raised?
- Ambagon Therapeutics has disclosed $55.4M raised across 3 rounds.
- Where is Ambagon Therapeutics headquartered?
- Ambagon Therapeutics is headquartered in Eindhoven, US.